Research Analysts Offer Predictions for STERIS’ Q3 Earnings

STERIS’ (TSE:STE) – Analysts at Atb Cap Markets cut their Q3 2025 earnings per share estimates for shares of STERIS’ in a research note issued on Wednesday, June 11th. Atb Cap Markets analyst W. Syed now anticipates that the company will post earnings of $0.22 per share for the quarter, down from their prior estimate of $0.28. Atb Cap Markets also issued estimates for STERIS’’s Q4 2025 earnings at ($0.10) EPS, FY2025 earnings at $0.57 EPS, Q1 2026 earnings at $0.42 EPS, Q2 2026 earnings at $0.14 EPS, Q3 2026 earnings at $0.31 EPS, Q4 2026 earnings at ($0.02) EPS and FY2026 earnings at $0.84 EPS.

Separately, Raymond James cut STERIS’ from a “moderate buy” rating to a “hold” rating in a report on Wednesday, April 9th.

STERIS’ Price Performance

STERIS’ Company Profile

STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.